29 related articles for article (PubMed ID: 32157418)
1. The Risk and Predictors of Malignancies in Ankylosing Spondylitis Patients in Israel-A Retrospective Electronic Data-Based Study.
Kagan P; Horesh N; Amital H; Tsur AM; Watad A; Cohen AD; Ben-Shabat N
J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568555
[TBL] [Abstract][Full Text] [Related]
2. Uncovering the Challenges of Rare Diseases: Insights From a Retrospective Cross-Sectional Study in Albania (2005-2022).
Perolla A; Çalliku E; Cili A; Caja T; Pulluqi P; Ivanaj A
Cureus; 2024 Jan; 16(1):e52091. PubMed ID: 38222997
[TBL] [Abstract][Full Text] [Related]
3. Cancer Risk in Patients with Gaucher Disease Using Real-World Data.
Revel-Vilk S; Zimran A; Istaiti M; Azani L; Shalev V; Chodick G; Manor O; Paltiel O
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137776
[TBL] [Abstract][Full Text] [Related]
4. Refining patients' care in myelofibrosis: looking at second primary malignancies.
Polverelli N; Malagola M; Russo D
Leuk Lymphoma; 2022 Dec; 63(14):3274-3275. PubMed ID: 36648137
[No Abstract] [Full Text] [Related]
5. Real-world data of the use of rivaroxaban in pediatric patients with hematologic malignancies.
Sultan N; Pelland-Marcotte MC; Remy M; Champagne J; Laverdière C; Winikoff R; Tran TH
Leuk Lymphoma; 2024 Apr; 65(4):538-540. PubMed ID: 38170575
[No Abstract] [Full Text] [Related]
6. Hematologic Malignancies and Increased Cardiovascular Risk-Can More Be Done to Mitigate?
Gue YX; Lip GYH
Am J Cardiol; 2024 Feb; 213():182-183. PubMed ID: 38160921
[No Abstract] [Full Text] [Related]
7. Cephalosporin-induced encephalopathy in patients with hematologic malignancies: a significant concern.
Park YS; Kim MK; Lee KH; Koh SA; Jung JY; Jang BI; Lee SJ
J Yeungnam Med Sci; 2023 Nov; 40(Suppl):S137-S141. PubMed ID: 37960835
[No Abstract] [Full Text] [Related]
8. Correction to: The relationship between hematologic malignancies on male hypogonadism: a scoping review.
Sex Med Rev; 2024 May; ():. PubMed ID: 38697620
[No Abstract] [Full Text] [Related]
9. The NCCN 2023 Annual Congress: Hematologic Malignancies.
Denlinger CS
J Natl Compr Canc Netw; 2023 Nov; 21(Suppl):1. PubMed ID: 38016284
[No Abstract] [Full Text] [Related]
10. Is Treatment for Cytopenic Myelofibrosis Still an Unmet Clinical Need?
Caduc MJ; Koschmieder S
Hemasphere; 2023 Nov; 7(11):e982. PubMed ID: 37928624
[No Abstract] [Full Text] [Related]
11. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management.
Tefferi A
Am J Hematol; 2021 Jan; 96(1):145-162. PubMed ID: 33197049
[TBL] [Abstract][Full Text] [Related]
12. Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.
Tzeng HE; Lin CL; Tsai CH; Tang CH; Hwang WL; Cheng YW; Sung FC; Chung CJ
PLoS One; 2013; 8(7):e68041. PubMed ID: 23844152
[TBL] [Abstract][Full Text] [Related]
13. The age-risk relationship of hematologic malignancies in patients with rheumatoid arthritis: a nationwide retrospective cohort study.
Lin YC; Chou HW; Tsai WC; Yen JH; Chang SJ; Lin YC
Clin Rheumatol; 2015 Jul; 34(7):1195-202. PubMed ID: 25990004
[TBL] [Abstract][Full Text] [Related]
14. Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients.
Mora B; Rumi E; Guglielmelli P; Barraco D; Maffioli M; Rambaldi A; Caramella M; Komrokji R; Gotlib J; Kiladjian JJ; Cervantes F; Devos T; Palandri F; De Stefano V; Ruggeri M; Silver RT; Benevolo G; Albano F; Cavalloni C; Pietra D; Barbui T; Rotunno G; Cazzola M; Vannucchi AM; Giorgino T; Passamonti F
Cancer Med; 2019 Aug; 8(9):4089-4092. PubMed ID: 31173472
[TBL] [Abstract][Full Text] [Related]
15. The treatment of hematologic malignancies in pregnancy.
Vandenbriele C; Dierickx D; Amant F; Delforge M
Facts Views Vis Obgyn; 2010; 2(2):74-87. PubMed ID: 25302102
[No Abstract] [Full Text] [Related]
16. Association between myelofibrosis and risk of non-hematologic malignancies: a population-based retrospective cohort study.
Saliba W; Khudyakova M; Mishchenko E; Cohen S; Rennert G; Preis M
Ann Hematol; 2020 May; 99(5):1007-1016. PubMed ID: 32157418
[TBL] [Abstract][Full Text] [Related]
17. Association between myelofibrosis and thromboembolism: A population-based retrospective cohort study.
Saliba W; Mishchenko E; Cohen S; Rennert G; Preis M
J Thromb Haemost; 2020 Apr; 18(4):916-925. PubMed ID: 32017387
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
